Profile Category: Scientific Advisory Board

Christiana (Chris) Bardon, MD

Christiana Bardon, MD

Dr. Christiana (Chris) Bardon is Co-Managing Partner of MPM BioImpact and leads the firm’s public market investing as portfolio manager for BioImpact Equities and the

Sangeeta Bhatia, MD, PhD

Sangeeta N. Bhatia is a cancer researcher, Massachusetts Institute of Technology professor and biotech entrepreneur who adapts technologies developed in the computer industry for medical

James Bradner, MD

James (Jay) Bradner, MD is President of the Novartis Institutes for BioMedical Research (NIBR). Prior to joining Novartis, Dr. Bradner was on the faculty of

Gerald Chan, PhD

Gerald Chan co-founded Morningside in 1986 as a private investment group with venture capital, private equity and property investments. In the life science sector, Morningside

Susan Hockfield, PhD

Susan Hockfield is Professor of Neuroscience and President Emerita at the Massachusetts Institute of Technology; she served as the sixteenth president from 2004 to 2012,

Ted Love, MD

Dr. Love has served as GBT’s president and chief executive officer since 2014 and as a member of its Board of Directors since September 2013.

Caroline Popper, MD, PhD

My deep personal interest and is in the development and commercialization of new life science and medical technology. In particular, I focus on technology innovation